November 14, 2024 at 11:31 am

Beachbody Shapes Up and Reports Fourth Consecutive Quarter of Positive Adjusted EBITDA

The Beachbody Co (BODI) announced Q3 financial results reporting revenues of $102M, in line with the midpoint of their guidance range. Gross margins improved significantly, increasing 880 basis points year-over-year to 67.3%. Adjusted EBITDA was $10.1M, substantially exceeding the guidance range of $2M to $6M. This marks the company’s fourth consecutive quarter of positive adjusted… [Read More]
November 14, 2024 at 9:54 am

KORU Medical Systems Delivers Third Straight Quarter of Double-Digit Growth, Raises 2024 Outlook Amid Strong Q3 Results

KORU Medical Systems, Inc. (NASDAQ: KRMD), a leader in innovative subcutaneous infusion solutions, reported strong financial results for Q3 2024, marking its third consecutive quarter of double-digit growth. The company raised its full-year 2024 revenue, gross margin, and year-end cash guidance, reflecting strong business performance and strategic advancements. Q3 2024 Highlights: Net revenues of $8.2… [Read More]
November 14, 2024 at 8:40 am

Stocks making the biggest moves premarket: Disney, Cisco, ASML, Tapestry and more

Here’s a quick pre-market recap of the headlines making waves today: Disney stole the limelight with a surge of more than 9% following their outperformance of fiscal fourth-quarter estimates. The entertainment giant reported adjusted earnings of $1.14 per share on $22.57 billion revenue, surpassing projections. Cisco Systems, the networking behemoth, experienced a slight dip in… [Read More]
November 13, 2024 at 3:02 pm

AdTech and Media: Viant Reports a Strong Q3 and Announces Acquisition of Iris TV

A leading advertising software company that enables marketers to plan, execute and measure omnichannel ad campaigns through a cloud-based platform, Viant Technology, Inc. (DSP) had a strong third quarter, exceeding guidance across all key metrics. Revenue grew 34% year-over-year (y/y) to $79.9M, and contribution ex-TAC grew 21% to $47.4M. The company saw record quarterly spend… [Read More]
November 13, 2024 at 1:36 pm

NOONAN! TopGolf-Callaway Slices 2024 Guidance and Hits 52 Week Low

TopGolf-Callaway (MODG) reported its Q3 results that topped estimates on both EPS at $0.02 vs FactSet ($0.17) and revenues of $1.01Bn vs FactSet $981.8M. However, its outlook took a bogey as guidance came in below expectations on Q4 revenue ($885M vs FactSet $926.8M) and Q4 adjusted EBITDA ($74-$84M vs FactSet $104.7M). Additionally, the company lowered… [Read More]
November 13, 2024 at 1:20 pm

Stocks making the biggest moves midday: Rivian, Cava, Rocket Lab, Amgen and more

Here’s a midday trading report featuring top companies you need to know about: Charter Communications and Liberty Broadband are in the news as Charter agreed to buy Liberty Broadband with an all-stocks deal, causing their shares to fluctuate. Cava Group’s stock jumped 7% post third-quarter results that beat expectations. The Mediterranean-inspired food chain reported a… [Read More]
November 13, 2024 at 1:06 pm

Is It a Small World After All? Analysts Predict Surge in Small-Cap Stocks Following Trump’s Victory

Analysts are forecasting a strong market rally for small-cap stocks following the recent U.S. presidential election, highlighting their potential to outperform larger indices like the S&P 500. According to Tom Lee, Head of Research at Fundstrat Global Advisors, “small-cap stocks could gain up to 100% over the next several years” due to anticipated pro-growth policies…. [Read More]
November 13, 2024 at 10:36 am

Syros Pharmaceuticals Stock Plummets as Phase 3 Trial Falls Short of Primary Goal

Syros Pharmaceuticals (NASDAQ: SYRS) stock plunged 92% in post-market trading on Tuesday following the announcement that its Phase 3 SELECT-MDS-1 trial of tamibarotene, combined with azacitidine for newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) patients with RARA gene overexpression, failed to meet its primary endpoint. Tamibarotene is an oral, selective retinoic acid receptor alpha (RARα) agonist…. [Read More]